Pharma and Healthcare

Are these 3 pharma companies the market’s best-kept secret? Their numbers say yes.

Three pharma companies that have delivered the highest average 5-year ROCE are all into manufacturing the same type of products.…

November 2, 2025 08:32 IST

Roche vs Natco: Delhi HC dismisses Roche's plea

Delhi HC dismisses Swiss pharma giant’s injunction plea: All we know

After months of hearings, the Delhi High Court delivered the landmark ruling which cleared the way for Natco Pharma to…

Updated: October 10, 2025 11:35 IST

India's Revised PRIP Scheme: A Boost for Pharma R&D or Still Falling Short of Novel Drug Dreams?

New pharma R&D scheme helpful only for incremental products: Experts

Industry experts debate if the revised Promotion of Research and Innovation in Pharma-MedTech Sector (PRIP) scheme, with a Rs 5,000 crore…

October 5, 2025 18:04 IST

Roche Pharma Commits $1.9 Billion Investment in India Over 5 Years.

Roche commits $1.9 bn investment in India over next 5 yrs

Swiss healthcare giant Roche Pharma announced a major expansion, committing 1.5 billion Swiss francs ($1.9 billion) investment in India over…

October 2, 2025 05:15 IST

Drug maker Lupin on Monday said its subsidiary has inked a pact to fully acquire Amsterdam-headquartered VISUfarma BV

Lupin buys Amsterdam-based VISUfarma for Euro 190 million to boost speciality eye care portfolio

Lupin to acquire VISUfarma for €190 million, enhancing its European presence and ophthalmology portfolio with over 60 eye health products.

September 29, 2025 10:43 IST

ICICI Lombard Dividend 2025: Check record date, eligibility, and other key details

Dividend stocks: Glenmark Pharma only stock to trade ex-dividend this week

Dividend stocks this week, September 28: Glenmark Pharma trades ex-dividend on Oct 3; watch for interim Rs 2.5 payout. Check…

September 28, 2025 07:00 IST

Pharma Stocks Slump on US 100% Tariff News, But Experts Say Generic Exports are Safe.

Pharma stocks fall on 100% US tariff on branded drugs; no immediate impact, but threat to generics stays

Indian pharma stocks fell up to 7% in reaction to the US imposing a 100% tariff on imported branded and…

September 26, 2025 19:44 IST

Nifty Pharma index today, Nifty Pharma down, Indian pharma stocks fall

Pharma stocks crack, Nifty Pharma Index slips over 2% as Trump unveils 100% tariff: 3 key factors investors must watch

Nifty Pharma index drops over 2% after Trump unveils 100% tariff on drug imports – see which stocks are most…

September 26, 2025 11:50 IST

Natco Pharma is going to demerge its agro business from the core pharmaceutical business.

Natco Pharma demerger plan approved by board: What it means for agro and core pharma business

Natco Pharma plans to demerge its agro business from core pharma to unlock value, enhance focus, and ensure dedicated management.

September 25, 2025 12:05 IST

Scheme to boost innovation in pharma sector soon, says DoP secretary

The scheme, announced in August 2023, is aimed at fostering innovation in the pharmaceutical and medical devices sectors, with a total financial…

September 17, 2025 08:23 IST

Re-labelling not mandatory; GST benefits on medicines from Sept 22

Govt says relabelling for medicine packs not mandatory, manufacturers must issue a revised price list

Government clarifies re-labelling of medicines is not mandatory as new GST rates take effect from September 22.

Updated: September 16, 2025 16:33 IST

Zydus launches India’s first trivalent influenza vaccine VaxiFlu for seasonal flu protection

Zydus Lifesciences has launched VaxiFlu, India’s first trivalent influenza vaccine for seasonal flu protection. The vaccine follows WHO’s 2025–26 guidelines…

September 2, 2025 15:41 IST

Explainer: Why data exclusivity in pharma could be risky

Allowing data exclusivity would prevent the drug regulator — Central Drugs Standard Control Organisation — from granting marketing approval for…

Updated: August 26, 2025 15:59 IST

Trump’s tariff threats are spooking pharma. Are MNC stocks the answer?

Investors are increasingly turning to ‘safer’ MNC pharma stocks with a domestic focus at a time when the Trump administration…

August 19, 2025 15:49 IST

Big pharma bet: Jefferies lists out India’s next CRDMO multibaggers with up to 37% upside potential

Growth prescription: The future is specialty; Sun Pharma, Dr Reddy’s, Cipla lead, says Nomura

Nomura’s June 2025 analysis shows Indian pharma majors like Sun Pharma, Dr. Reddy’s, Cipla, Lupin, and Zydus posting strong specialty…

August 11, 2025 16:58 IST

Sun Pharmaceutical share price today, Sun Pharma, Sun Pharma stock, Sun Pharma share price

Sun Pharma slides 6% but Motilal Oswal recommends Buy: 3 reasons why

Sun Pharma slides 6% after weak Q1 FY26 results, but Motilal Oswal still recommends Buy—discover the three reasons to consider…

August 1, 2025 14:04 IST

diabetes, apollo hospitals, healthcare, health, wellness, insurance

Can stem cell therapies cure chronic diseases? Dr Gaurav Kharya on future of personalised medicines

Dr Gaurav Kharya of Indraprastha Apollo Hospitals explains how stem cell therapies could potentially cure severe Type 1 diabetes. Explore…

July 26, 2025 21:21 IST

Related News

An incorrect name on your Aadhaar can lead to severe issues with KYC (Know Your Customer) compliance, bank accounts, and benefits distribution.

Aadhaar card online update: How to change name, address, date of birth and phone number online in simple steps

8th Pay Commission: 69 lakh pensioners 'kept out' of new pay panel's coverage; employees' body seeks Terms of Reference revision

8th Pay Commission: Lakhs of pensioners ‘kept out’ of new pay panel’s coverage; union seeks Terms of Reference revision

e-Aadhaar app launch in India: Update your date of birth, address and phone number instantly with the upcoming all-in-one app soon

Greaves Electric Briefly Tops Ola in E2W Sales as Competition Intensifies

Greaves Electric overtakes Ola in E2W sales, pushes it out of top five

Step-by-Step guide to retrieve your Aadhaar Card number or enrolment ID

Aadhaar Card update: Lost or forgot your Aadhaar? Here’s how to retrieve it online or offline

In sub-4m SUV arena, homegrown Tata outpaces Korean rivals

1 hr ago

Tata Motors’ Nexon and Punch remain top sellers in the sub-4 metre compact SUV segment, outperforming four rivals from Hyundai and Kia. This trend has been ongoing, with Nexon being one of the country’s best-selling cars. Tata’s emphasis on safety and various powertrain options has contributed to its success, while Hyundai and Kia’s feature-rich models have had varying levels of success.

View all shorts